1-2 of 2
Liang Phuong-Dung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma

Shaji K. Kumar, MD, Prashant Kapoor, MD, Betsy Laplant, MS, Liang Phuong-Dung, Eli Muchtar, MD, Francis K. Buadi, MB, CHB, Wilson I Gonsalves, MD, Gabriella C Malave, BA, Alanna M. Vossen, David Dingli, MD PhD, Ronald S. Go, MD, Rahma M Warsame, MD, Taxiarchis Kourelis, MD, Yi L. Hwa, NP, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, John A. Lust, MD PhD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Morie A. Gertz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-139372
Published: 2020
Journal Articles

Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients with Multiple Myeloma with Extramedullary Disease or Plasma Cell Leukemia

Francis K. Buadi, MB, CHB, Martha Q. Lacy, MD, Gabriela Perez, MS, Liang Phuong-Dung, Ankit Kansagra, MD, Thomas E. Witzig, MD, Dania Kaehlyn Helgeson, Karen Woolley, Daniel Auclair, Hearn Jay Cho, MD PhD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-142641
Published: 2020